Novel biomarker for diagnosis of lung cancer
AssigneeSeoul National University R&Db Foundation
InventorJe Yoel CHO
Life of this patent
Estimating the term…
Abstract
Disclosed are a composition for diagnosis of lung cancer including an antibody specific to GPI specific phospholipase D1 (GPLD1) protein, which is an effective biomarker for early diagnosis of lung cancer, and a composition for diagnosis of lung cancer including a primer or probe specific to a nucleic acid encoding the GPLD1 protein. The lung cancer diagnostic marker may be effectively used in early diagnosis of lung cancer and also, is very useful for evaluating progression of a disease and prognosis before and after treatment of the same.
Claims8
A composition for diagnosis of lung cancer, comprising an antibody or polypeptide specifically bound to glycosylphosphatidylinositol (GPI) specific phospholipase D1 (GPLD1) protein.
A kit for diagnosis of lung cancer, comprising an antibody or polypeptide specifically bound to GPLD1 protein.
A micro-array for diagnosis of lung cancer, comprising an antibody or polypeptide specifically bound to GPLD1 protein.
A protein chip for diagnosis of lung cancer, comprising an antibody or polypeptide specifically bound to GPLD1 protein.
A composition for diagnosis of lung cancer, comprising a primer or probe specific to a nucleic acid encoding GPLD1 protein.
A kit for diagnosis of lung cancer, comprising a primer or probe specific to a nucleic acid encoding GPLD1 protein.
A micro-array for diagnosis of lung cancer, comprising a primer or probe specific to a nucleic acid encoding GPLD1 protein.
A DNA chip for diagnosis of lung cancer, comprising a primer or probe specific to a nucleic acid encoding GPLD1 protein.
Dependencies are inferred from the claim text.